Biotech Networks noted that Argonaut Manufacturing Services LS/Dx Business announced a transition to Aluris Sciences backed by 1315 Capital.
Public source
Publisher name
Public post
bionetworks Trending News: Argonaut Manufacturing Services LS/Dx Business Announces Transition to Aluris Sciences, Backed by 1315 Capital https://lnkd.in/eUg_uEaM Same m…
Company
Biotech Networks
Accelerating life science research and product development by connecting biotech professionals and companies
- Industry
- Biotechnology
- Location
- Arlington, US
- Company size
- 2–10 employees
About Biotech Networks
Biotech Networks accelerates life science research and product development by connecting biotech professionals within and between geographic hubs using web-based technologies and virtual and in person events.
See moreLatest activity
Latest activity from Biotech Networks
5 signals
Partnerships
Biotech Networks announced the results of Onymos and Vanta Diagnostics collaborating to scale intelligent lab intake.
Partnerships
Biotech Networks announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets.
Presence & Recognition
Biotech Networks hosted a free workshop titled Biotech Networks Connect on September 9th at 4 pm PT and 7 pm ET to discuss leveraging LinkedIn for life science career growth.
Discover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
BioHealth Innovation, Inc.
BioHealth Innovation, Inc. noted that Bruker made a majority investment in MIMETAS to expand its drug discovery capabilities with organ-on-a-chip and human physiology-relevant models.
Strategy & Corporate Development
MLM Medical Labs
MLM Medical Labs announced that it is a wholly owned subsidiary of Labcorp.
Strategy & Corporate Development
VION Biosciences
VION Biosciences announced the acquisition of Prolytix, which adds regulated large-molecule bioanalytical and CMC services alongside reagents and diagnostic workflow inputs.
Strategy & Corporate Development
Portal Innovations
Portal Innovations acquired the Portal portfolio company CrossBridge Bio for up to $300 million.
Strategy & Corporate Development
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA